Biogen Appoints Michael Ehlers Executive Vice President, Research and Development
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Biogen (NASDAQ: BIIB) today announced the appointment of Michael Ehlers, M.D., Ph.D., as executive vice president, Research and Development. Dr. Ehlers will oversee...